Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.
about
Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumorsInfluence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectivesSCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagusRectal cancer treatment: improving the picture.Update on clinical radiobiologyPre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status.The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.Epidermal growth factor receptor inhibition and non-small cell lung cancer.Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma.HER family inhibitors in pancreatic cancer: current status and future directions.Molecular mechanisms of pancreatic cancer and potential targets of treatment.Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.Molecular targeted therapies for pancreatic cancer.Targeted therapy in colorectal carcinoma: more than a theory.Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.Receptor signaling as a regulatory mechanism of DNA repair.Revisiting the role of molecular targeted therapies in patients with brain metastases.Cetuximab: still an option in the treatment of pancreatic cancer?Cetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsRadiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.The kinase inhibitor D11 induces caspase-mediated cell death in cancer cells resistant to chemotherapeutic treatment.Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersDiagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo.Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells.Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests.Epidermal growth factor receptor-targeted therapy.EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!miRNAs: Important Targets for Oral Cancer Pain Research.Hypoxia in biology and medicine: the legacy of L H Gray.Oncology Gold Standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck.Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study.Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay.
P2860
Q24816432-0F58F6B7-8A32-4345-9F5C-42A5E2773538Q33243912-7DB42D55-6DE7-45B8-812D-3B4E5E5EA1FAQ33697847-DB310D4C-BE18-44AC-8CD2-364868780928Q33822929-530F9C92-AFE6-446A-B08D-9A5D9F8B2662Q34061012-EE6D0604-43B1-4272-B47F-C7232DA44B65Q34382761-1BD46050-9EA3-4252-AC9C-D05471A7C4E9Q34991321-AB3F7A1E-D097-4461-BD02-E5D62D0E015EQ35172674-B0ABE22D-E136-4A40-99C6-70975A0E4F27Q36253159-A6F8EE78-26B8-474D-B854-24BC66118F85Q36484536-FD30A211-80F2-44AC-A4D8-0813806634F2Q36488138-E8137F09-73CB-4FF8-A5A9-39E08CC5C3A5Q36504349-8449A613-6839-4769-942F-A30FE45B004BQ36713320-637B285A-E05F-46BD-A206-3E7AB1F0AB25Q36734936-E1B182A7-124E-4A5C-B7D3-0B64881C33B2Q36758436-705566A2-2161-4AAA-9C6E-226AA755BFC5Q36788485-28D3FF1F-3C4C-434F-BEDB-A82864B990EFQ36944441-66B8FEBD-6216-4504-A9C3-64E2AA67B487Q37079277-43D8E30D-35FB-4032-A2D3-995EB9493385Q37079854-3D1683A7-664C-4A8F-BC90-18D4A4CEE80BQ37368256-F56E13D6-A40E-467B-B850-05BDF0A6576EQ37904792-EBEEE624-5CB9-4887-AFDC-5E06F8480801Q38096424-BAD6EECA-233D-46ED-91DB-6C06748F819AQ38385570-82980471-F9AD-4D6A-9387-530E1511DD63Q38478878-37665DEB-8682-4777-98D1-1BEEC27CDDDAQ38564088-D9C7FCD6-CF91-4871-A9EE-4EE5B5EE8587Q38826790-8519A470-4CAB-4839-BA02-9F19C64DF679Q38911199-E8A48968-0609-45F6-8AEA-78C93CC659E3Q39000589-8B08071A-FEB0-4904-B398-53C3EB5BCB7EQ39515166-7679E538-B6FC-45F4-8B3A-FBC070C14F27Q39558253-9D6CA6BC-9BBF-4158-A441-143714C577D2Q39668021-5BC421F4-06CA-440C-BD26-DF71DBABD83EQ39696362-0912A261-DD27-475F-95FD-D470F02A0B8CQ40038133-501BE338-F753-4E77-AFD6-716324AC514CQ42382736-2D860BF8-6922-4619-B4F2-53AD57771ABBQ43102462-DE4B6E27-CDD3-4F7C-92D9-0CBB1683DB2BQ46902619-1C1B07F4-97D6-4B24-A247-378034613485Q48592806-B993183B-FE3A-4A57-BFDC-AA63360D4567Q49777008-C3A6A792-2920-4F98-96DE-5F6419205770Q50942238-D81F652A-398F-477D-A0EA-E916127956C5Q51749302-D73D122F-8FDE-4C3E-846C-5C40CD3FC2DB
P2860
Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Targeting the epidermal growth ...... clinical and clinical results.
@ast
Targeting the epidermal growth ...... clinical and clinical results.
@en
type
label
Targeting the epidermal growth ...... clinical and clinical results.
@ast
Targeting the epidermal growth ...... clinical and clinical results.
@en
prefLabel
Targeting the epidermal growth ...... clinical and clinical results.
@ast
Targeting the epidermal growth ...... clinical and clinical results.
@en
P1476
Targeting the epidermal growth ...... clinical and clinical results.
@en
P304
P356
10.1016/J.RADONC.2004.07.007
P577
2004-09-01T00:00:00Z